A grassroots international initiative

Ibogaine
for the
World

Securing the Medicine

Supporting an independent source of ibogaine for research, education, and humanitarian efforts worldwide.

Support the Mission Learn More

Why it matters

Building continuity, access, and trust.

Reliable Supply

Establishing a stable, independent source of high-quality ibogaine through ethical sourcing and careful manufacturing.

Research & Access

Supporting research and responsible access where permitted, and sharing knowledge across borders.

Global Mission

Working with international affiliates and communities to help build a durable global movement.

The Mission

A global mission to secure ibogaine.

Our goal is to establish a dedicated, independent source of high-quality ibogaine to support researchers, clinicians, organizations, and communities working around the world.

We are building the infrastructure needed to provide consistent access to this medicine—advancing research, supporting responsible treatment initiatives where permitted by law, and strengthening humanitarian efforts in countries where this work is taking place.

This project carries forward the work of people who came before us, with the aim of making reliable access possible for generations to come.

The Story

A continuation of a sacred work.

This mission carries forward a lineage rooted in the Bwiti tradition and in the work of the late ibogaine pioneer Howard Lotsof. His efforts helped bring ibogaine into public discussion as a possible interruption for severe substance dependence.

Today, an international network of advocates, researchers, clinicians, and community members continues that work. While individual regions are developing their own domestic pathways, much of the world still lacks dependable access to high-quality material and reliable production.

Our focus is larger than any one person. It is a long-term effort to build infrastructure, preserve knowledge, and serve the communities that need help most.

Historic Parkinson's Elixir poster artwork

Current Laboratory Work

Exploring ibogaine’s wider potential.

Interest in ibogaine extends beyond severe substance dependence. Advocates and researchers are also examining its possible neuroprotective and neuroregenerative properties in conditions such as Parkinson’s disease, multiple sclerosis, and traumatic brain injury.

The “Parkinson’s Elixir” label shown here is presented as part of the project’s history and current advocacy—not as evidence of an approved or proven treatment.

This content is provided for educational and advocacy purposes. Ibogaine is not approved by the U.S. Food and Drug Administration for the treatment of addiction, Parkinson’s disease, or other medical conditions. Medical claims require appropriate clinical evidence and regulatory review.

Help Secure the Supply

Your support makes this possible.

Contributions will help support raw-material sourcing, transportation, laboratory operations, manufacturing continuity, and international coordination.

PayPalVenmoZelle
Donation links coming soon.